Processa Pharmaceuticals, Inc. Increase (Decrease) in Inventories
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Inventories of -$7.07 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-09-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2017-09-25
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2015-12-31 was $15.13K.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2015-09-30 was -$42.37K, a 866.68% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2015-06-30 was -$4.07K, a 107.08% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2015-03-31 was $24.24K.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2015 was -$7.07K.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2014 was -$73.08K.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2013 was -$97.37K.
- Processa Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2012 was -$48.75K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed | Increase (Decrease) in Inventories 27 month | Increase (Decrease) in Inventories 30 month | Increase (Decrease) in Inventories 33 month | Increase (Decrease) in Inventories 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $15.13K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$27.24K derived: sum of 2 quarters · filed 2017-09-25 | -$31.31K derived: sum of 3 quarters · filed 2017-09-25 | -$7.07K 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | -$42.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$46.44K derived: sum of 2 quarters · filed 2017-09-08 | -$22.19K 10-Q · filed 2017-09-08 | -$19.38K 10-Q · filed 2015-12-01 | -$39.07K derived: sum of 4 quarters · filed 2017-09-08 | |||||||
| 2015-06-30 | -$4.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $20.17K 10-Q · filed 2017-08-30 | $22.99K 10-Q · filed 2015-08-19 | $3.29K derived: sum of 3 quarters · filed 2017-08-30 | $8.82K derived: sum of 4 quarters · filed 2017-08-30 | |||||||
| 2015-03-31 | $24.24K 10-Q · filed 2017-08-07 | $24.89K 10-Q · filed 2015-05-15 | $7.37K derived: sum of 2 quarters · filed 2017-08-07 | $12.89K derived: sum of 3 quarters · filed 2017-08-07 | $70.39K derived: sum of 4 quarters · filed 2017-08-07 | |||||||
| 2014-12-31 | -$16.88K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | -$11.35K derived: sum of 2 quarters · filed 2017-06-19 | $46.15K derived: sum of 3 quarters · filed 2017-06-19 | -$73.08K 10-K · filed 2017-06-19 | -$77.47K 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | $5.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $63.03K derived: sum of 2 quarters · filed 2015-12-01 | -$56.21K 10-Q · filed 2015-12-01 | $4.68K derived: sum of 4 quarters · filed 2015-12-01 | ||||||||
| 2014-06-30 | $57.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$61.73K 10-Q · filed 2015-08-19 | -$850.00 derived: sum of 3 quarters · filed 2015-08-19 | -$9.48K derived: sum of 4 quarters · filed 2015-08-19 | ||||||||
| 2014-03-31 | -$119.24K 10-Q · filed 2015-05-15 | -$58.35K derived: sum of 2 quarters · filed 2015-05-15 | -$66.98K derived: sum of 3 quarters · filed 2015-05-15 | -$202.71K derived: sum of 4 quarters · filed 2015-05-15 | -$265.35K 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $60.88K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $52.25K derived: sum of 2 quarters · filed 2015-04-14 | -$83.48K derived: sum of 3 quarters · filed 2015-04-14 | -$97.37K 10-K · filed 2015-04-14 | -$146.12K 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | -$8.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$144.36K derived: sum of 2 quarters · filed 2014-11-13 | -$158.25K 10-Q · filed 2014-11-13 | -$159.19K derived: sum of 4 quarters · filed 2014-11-13 | -$207.00K 10-Q · filed 2013-11-08 | |||||||
| 2013-06-30 | -$135.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | -$149.62K 10-Q · filed 2014-08-19 | -$150.56K derived: sum of 3 quarters · filed 2014-08-19 | -$135.90K derived: sum of 4 quarters · filed 2014-08-19 | -$198.37K 10-Q/A · filed 2013-09-06 | |||||||
| 2013-03-31 | -$13.89K 10-Q · filed 2014-05-14 | -$14.82K derived: sum of 2 quarters · filed 2014-05-14 | -$166.00 derived: sum of 3 quarters · filed 2014-05-14 | |||||||||
| 2012-12-31 | -$934.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $13.72K derived: sum of 2 quarters · filed 2014-03-27 | -$48.75K 10-K · filed 2014-03-27 | |||||||||
| 2012-09-30 | $14.66K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | -$47.81K 10-Q · filed 2013-11-08 | ||||||||||
| 2012-06-30 | -$62.47K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |